Truist Financial’s QIAGEN NV QGENF Stock Holding History

Truist Financial’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-10,478	Closed	-$209K	–	784
2013 Q2	$209K	Buy	+10,478	New	+$209K	0.01%	690

Other funds holding QGENF

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Truist Financial's QGENF Position: Q3 2013 in Review

Truist Financial sold out of QIAGEN NV (QGENF) in Q3 2013, closing a stake of 10,478 shares — an estimated $209K sold.

Truist Financial first reported a position in QGENF in Q2 2013 and held it in 1 quarter. The position peaked at $209K in Q2 2013. 150 funds tracked by Wall St. Rank hold QGENF as of Q3 2013.

Truist Financial reported no remaining QIAGEN NV position as of Q3 2013 after selling out during the quarter.
Truist Financial sold 10,478 QIAGEN NV shares in Q3 2013, an estimated $209K.
Truist Financial first reported a position in QIAGEN NV in Q2 2013 and held it in 1 quarter.
Truist Financial's QIAGEN NV position peaked at $209K in Q2 2013.
150 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2013.

Based on Truist Financial's 13F filing for Q3 2013, filed 22 Oct 2013.